Drug Shortage Report for JAMP-RISEDRONATE
Report ID | 35443 |
Drug Identification Number | 02368552 |
Brand name | JAMP-RISEDRONATE |
Common or Proper name | RISEDRONATE SODIUM |
Company Name | JAMP PHARMA CORPORATION |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | RISEDRONATE SODIUM |
Strength(s) | 35MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 4 |
ATC code | M05BA |
ATC description | DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-01-08 |
Estimated end date | |
Actual end date | 2018-10-12 |
Shortage status | Resolved |
Updated date | 2018-10-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2018-10-15 | French | Compare |
v7 | 2018-10-15 | English | Compare |
v6 | 2018-10-15 | French | Compare |
v5 | 2018-10-15 | English | Compare |
v4 | 2018-02-05 | French | Compare |
v3 | 2018-02-05 | English | Compare |
v2 | 2018-01-09 | French | Compare |
v1 | 2018-01-09 | English | Compare |
Showing 1 to 8 of 8